Gasgon Medical
Gasgon Medical is a Cork, Ireland-based medical device startup developing AirVault®, a patented single-use device that removes air bubbles from IV infusions. The pre-revenue company targets hospitals, home infusion providers, and specialty care markets across the EU and US.
- Company typePrivate
- Founded2016
- HeadquartersCarrigaline, Ireland
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Gasgon Medical does
Gasgon Medical is a Cork, Ireland-based medical device startup (legally Tessen Solutions Ltd t/a Gasgon Medical) founded by Vincent Forde in 2016, developing AirVault® — a patented, single-use, closed-system device that captures and removes air bubbles from IV fluids during infusion administration. The product addresses a high-frequency clinical problem: more than 80% of hospital patients receive IV medicine, and air-in-line events cause alarm fatigue, maintenance delays, hazardous drug exposure risk, and potential vascular air embolism. AirVault® is targeted at hospitals, cancer and oncology centers, home infusion providers, and specialty care settings including pediatrics, cardiology, and intensive care. The company is pre-revenue, with US commercialization pending 510(k) clearance and EU launch contingent on CE marking.
The company's technology is protected by a broad international IP portfolio including granted US Patent No. 12,239,773, granted patents in China (ZL201980090735.9), Europe (3917643), and Japan (7321276), the registered AirVault® trademark, six EU design registrations, and multiple pending applications across the US, EU, China, Japan, Israel, and two PCT filings. Clinical validation is in progress through the €3 million EU-funded Swirl SAFE-infusion consortium with Tada Medical and Remote Signals, including hospital trials at Centro Hospitalar e Universitário de Coimbra (CHUC, Portugal) and Parc Sanitari Sant Joan de Déu (PSSJD, Spain). The company is supported by Enterprise Ireland, EIT Health, the European Innovation Council, Health Innovation Hub Ireland, and Cork County Council, and has accumulated numerous awards including the 2023 NHIA Innovation Award, 2023 National Startup Awards Gold in Medtech, 2021 InterTradeIreland Seedcorn overall winner, and 2nd place at the 2019 EIT Health European Health Catapult.
Gasgon Medical operates a consumable-based revenue model via single-use IV safety device sales to enterprise healthcare providers, with go-to-market executed through direct enterprise field sales and channel support from Enterprise Ireland. The team of 1-10 employees includes a CFO (Dan Stapleton), CTO (Pauric Carey, 10+ years Class I-III medical device experience), Lead Design Engineer (James Roche, ISO 13485 expertise), and a Clinical Advisory Board of infusion nursing and respiratory therapy experts. Total funding to date is approximately €2.25 million in equity from a 2022 seed round led by Furthr VC (with Enterprise Ireland, HBAN, and Irrus Investments) plus the €3 million EIC grant and roughly €150,000 in cumulative prize money. Pricing is not publicly disclosed, the product is not yet available for sale in the US, and the company is positioning for sequential EU and US market entry.
Gasgon Medical firmographics
Firmographics- Name
- Gasgon Medical
- Legal name
- Tessen Solutions Ltd t/a Gasgon Medical
- Website
- https://gasgonmedical.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Gasgon Medical is a Cork, Ireland-based medical device startup developing AirVault®, a patented single-use device that removes air bubbles from IV infusions. The pre-revenue company targets hospitals, home infusion providers, and specialty care markets across the EU and US.
- Ownership category
- akta.pro rank
Gasgon Medical industry classification
Industry- Product category
- Medical Devices - IV Infusion Safety
- akta.pro primary industry
- Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers) (HLAHAGAK)
Keywords
Where Gasgon Medical is headquartered
LocationHeadquarters
- HQ city
- Carrigaline
- HQ country
- Ireland
- HQ region
- Europe
Offices1 record
Markets served
Gasgon Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: Pre-revenue medical device company preparing to launch its first range of products. AirVault® is a single-use device indicating a consumable/repeat purchase revenue model once commercialized.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Gasgon Medical product offering
Product offeringCore offering
Gasgon Medical is a medical device company developing and commercializing AirVault®, a patented single-use device designed to capture and remove air bubbles from IV fluids during infusion administration. The product is intended for hospitals, cancer centers, infusion centers, and home infusion providers to reduce IV delivery alarms, maintenance delays, and patient safety risks including vascular air embolism. The company is pre-revenue and preparing for its first commercial launch in the EU, with US market entry pending 510(k) FDA clearance.
Product overview
Gasgon Medical offers a single core product, AirVault®, a single-use IV safety device that removes air bubbles from IV fluids during infusion administration. The company is an award-winning medical device startup preparing to launch its first product range in the clinical market, with a focus on fluid management solutions for IV infusions.
Differentiator
Problem solved
Functional benefit
Brands
- AirVault®: A patented single-use medical device to remove air bubbles from IV fluids during administration. A closed-system air trap that proactively removes air in line.
Products and services
- AirVault® AirVault® is a patented single-use medical device designed to capture and remove air bubbles from IV fluids during infusion administration. It is intended for hospitals, cancer centers, infusion centers, and home infusion providers to reduce IV delivery alarms, maintenance delays, and patient safety risks including vascular air embolism.
Quantifiable outcome
- AirVault® selected as overall winner at National Home Infusion Awards (NHIA) 2023, recognized as 'game-changing' infusion industry product by expert clinician panel
- +2 more outcomes
Companies that use Gasgon Medical
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles3 records
Gasgon Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Gasgon Medical partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- Tada MedicalcoreTwo-year Swirl SAFE-infusion project awarded €3 million from European Innovation Council. Joint collaboration to improve safety of IV infusions for patients and care providers. Collaboration examining how shifting IV therapy from hospital to home will affect risk management for vascular air embolism and IV line dislodgement.
- EIT HealthcoreEIT Health supported Gasgon Medical with €50,000 Headstart Funding Programme 2018, selected for European Health Catapult competition, participated in InterTradeIreland Seedcorn. EIT Health is a European health innovation network providing acceleration and market access support.
- HealthInnovationHubIreland (HIHI)minorSelected for acceleration within Irish healthcare system. Listed among 20 Irish companies disrupting health-tech sector. HIHI Open Call promotion including CTO interview for innovation brochure.
- Centro Hospitalar e Universitário de Coimbra (CHUC)coreWorking with clinical team at CHUC, a leading healthcare institute in Portugal, for SAFE-Infusion project. Project selected by CHUC to further their commitment to improving patient safety and healthcare performance through IV device development.
- Parc Sanitari Sant Joan de Déu (PSSJD) / Fundació Sant Joan de Déu (FSJD)coreCollaborating with leading Barcelona research foundation to prepare IV infusion devices for launch. Clinical team at PSSJD committed to improving safety and clinical outcomes with strong potential identified in Gasgon's technology.
- European Federation of Nurses (EFN)minorMet with Secretary General Paul De Raeve in Brussels to discuss important role EFN plays advocating for its 3 million nurse members across EU and wider role MedTech innovation can play to reduce burden of care at bedside.
- Remote SignalsminorPart of Swirl SAFE-infusion consortium alongside Tada Medical to determine if technology can be used to improve infusion of IV drugs.
- Cork County CouncilminorSelected for Cork County Council national campaign to travel to Boston as one of twelve Irish MedTech and LifeScience startups.
- Voisin Consulting - Neighborhood ProgramminorJoined prestigious Paris-based Neighborhood program delivered by Voisin Consulting to support regulatory journey ahead of planned EU launch.
- ACTION Innovation Network - InterACTION ProgramminorSelected for InterACTION Healthcare 2020 program as one of 5 companies from international cohort with focus on Boston and New England region for US market entry. Program delivered mentoring on FDA regulatory pathway, legal frameworks, investment and sales strategy.
Scale indicators6 records
Recent moves6 records
Expansion highlights7 records
Gasgon Medical competitors and assessment
Company assessmentDirect peers
- Elcam Medical: Israeli OEM/ODM manufacturer of single-use IV components and fluid-management devices used by global IV therapy brands. Comparable in scale and product type for IV consumables including air-handling and fluid path components.
- Tada Medical: Ireland-based IV drug delivery safety device company and Gasgon's co-development partner in the €3M EIC-funded Swirl SAFE-infusion project. Operates in the same IV air-in-line and infusion-safety niche with similar problem framing.
- Vygon: French-headquartered single-use IV catheter and accessory manufacturer. Operates in the same single-use IV consumable category with overlapping hospital customers in Europe and similar product economics.
- Smiths Medical: Manufacturer of IV infusion pumps and accessories (acquired by ICU Medical in 2022). Sells air-eliminating filters and IV sets directly competitive with the AirVault® use case, and bundles accessories with installed pump bases.
Broad incumbents
- ICU Medical: US-listed pure-play IV therapy company making IV pumps, sets, and accessories including air-eliminating filters. Operates the same hospital IV consumable market as Gasgon but across a much broader portfolio, and has acquired Smiths Medical.
- Baxter International: Global leader in IV solutions, infusion pumps, and IV administration sets. Sells through hospital formularies where AirVault® would need to be adopted, and controls pump architectures that determine whether accessory devices can attach.
- Becton, Dickinson and Company (BD): Diversified medical device conglomerate with a large IV therapy and infusion portfolio. BD's scale and contracts make it the dominant gatekeeper for IV consumable adoption in many hospital systems where Gasgon would sell.
- B. Braun Melsungen: German medical technology major with a strong IV therapy and infusion systems portfolio (Infusomat, Perfusor). Competes for the same IV administration set budgets and could integrate air-in-line mitigation directly into its consumable lines.
- Fresenius Kabi: Global IV solutions, infusion pumps, and clinical nutrition provider. Sells complete IV therapy stacks into hospitals — the same customers Gasgon would approach — and could easily extend into air-in-line accessories.
- Teleflex: Diversified medical device company with a vascular access and IV therapy portfolio. Operates in the same hospital procurement channels and offers competing single-use IV accessories at large scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Gasgon Medical social profiles
Digital presenceGasgon Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Gasgon Medical leadership team
Management profileNumber of profiles
Profiles11 records
Gasgon Medical funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Gasgon Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Gasgon Medical
What does Gasgon Medical do?
Gasgon Medical is a medical device company developing and commercializing AirVault®, a patented single-use device designed to capture and remove air bubbles from IV fluids during infusion administration. The product is intended for hospitals, cancer centers, infusion centers, and home infusion providers to reduce IV delivery alarms, maintenance delays, and patient safety risks including vascular air embolism. The company is pre-revenue and preparing for its first commercial launch in the EU, with US market entry pending 510(k) FDA clearance.
Is Gasgon Medical a public or private company?
Gasgon Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Gasgon Medical founded?
Gasgon Medical was founded in 2016. It employs 1 to 10 people.
Where is Gasgon Medical based?
Gasgon Medical is headquartered in Carrigaline, Ireland, in the Europe region.
How does Gasgon Medical make money?
One revenue line is on record: medical Device Sales.
Who are Gasgon Medical's main competitors?
Direct peers on record are Elcam Medical, Tada Medical, Vygon and Smiths Medical. Broad incumbents are ICU Medical, Baxter International, Becton, Dickinson and Company (BD), B. Braun Melsungen, Fresenius Kabi and Teleflex.
Does Gasgon Medical have an API?
No public API is recorded for Gasgon Medical.
What industry is Gasgon Medical in?
Gasgon Medical's product category is Medical Devices - IV Infusion Safety. Its primary akta.pro industry code is HLAHAGAK, Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers).